If you and your provider decide labs would be beneficial, common tests include hemoglobin A1c if you have diabetes or prediabetes to establish a new baseline, thyroid function if you are experiencing fatigue, lipid panel to assess cholesterol status, and comprehensive metabolic panel to check kidney and liver function
How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
Discard medication that appears cloudy, discolored, contains particles or crystals, or has separated into layers
Huang JJ, Ma SX, and Hou X, et al (2015) Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer Chin J Cancer 34 9498 PMCID: 4360078 10
If you experience symptoms suggestive of hypoglycaemia (tiredness, shakiness, sweating, confusion), check your blood glucose and treat appropriately with 15-20g of fast-acting carbohydrate (e.g., glucose tablets, fruit juice) if levels are below 4 mmol/L